Literature DB >> 20175412

Prevalence and determinants of tobacco smoking among HIV patients in North Eastern Nigeria.

O O Desalu1, P O Oluboyo, A B Olokoba, A O Adekoya, A Danburam, F K Salawu, J Midala.   

Abstract

People living with human immune deficiency virus (HIV) infection who smoke tobacco are more likely to develop several opportunistic infections, and also suffer complications from antiretroviral medication than the non smokers of tobacco. The burden of tobacco smoking amongst people living with this infection is poorly understood in the African population. The aim of this study was to establish the prevalence and determinants of tobacco smoking among HIV patients in North Eastern Nigeria. We enrolled 312 adult HIV sero-positive patients attending the Federal Medical Centre Yola, Nigeria. A modified World Health Organisation (WHO) recommended questionnaire was used to obtain information from consented subjects. The prevalence of current cigarette smoking among HIV patients was 22.1%. The male to female ratio of smokers was 2:1. Peer pressure (25.8%) and pleasure (25.8%) were reported as the most common reasons for smoking tobacco. Multivariate analysis shows that male gender, age ranged 40-49 years, alcohol drinking and CD4 T lymphocyte count <200 cells/mm3 were positively associated with tobacco smoking. The prevalence of tobacco smoking among HIV patients in North Eastern Nigeria was high. Therefore, smoking should be discouraged in people living with HIV to reduce their morbidity and mortality.

Entities:  

Mesh:

Year:  2009        PMID: 20175412

Source DB:  PubMed          Journal:  Afr J Med Med Sci        ISSN: 0309-3913


  7 in total

1.  Tobacco use among adults initiating treatment for HIV infection in rural Uganda.

Authors:  Gina R Kruse; David R Bangsberg; Judith A Hahn; Jessica E Haberer; Peter W Hunt; Conrad Muzoora; John P Bennett; Jeffrey N Martin; Nancy A Rigotti
Journal:  AIDS Behav       Date:  2014-07

Review 2.  Sex Differences in Tobacco Use Among Persons Living With HIV/AIDS: A Systematic Review and Meta-Analysis.

Authors:  Andrea H Weinberger; Philip H Smith; Allison P Funk; Shayna Rabin; Jonathan Shuter
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-01       Impact factor: 3.731

Review 3.  Smoking and HIV: prevalence, health risks, and cessation strategies.

Authors:  Alan R Lifson; Harry A Lando
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

Review 4.  Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries.

Authors:  Gerald S Bloomfield; Fawaz Alenezi; Felix A Barasa; Rebecca Lumsden; Bongani M Mayosi; Eric J Velazquez
Journal:  JACC Heart Fail       Date:  2015-08       Impact factor: 12.035

5.  Physicians are a key to encouraging cessation of smoking among people living with HIV/AIDS: a cross-sectional study in the Kathmandu Valley, Nepal.

Authors:  Rachel M Amiya; Krishna C Poudel; Kalpana Poudel-Tandukar; Jun Kobayashi; Basu D Pandey; Masamine Jimba
Journal:  BMC Public Health       Date:  2011-08-31       Impact factor: 3.295

6.  Etiology, clinical characteristics, and management of pleural effusion in Ilorin, Nigeria.

Authors:  Peter Oladapo Adeoye; Wahab Rotimi Johnson; Olufemi Olumuyiwa Desalu; Chima Pascal Ofoegbu; Ademola Emmanuel Fawibe; Alakija Kazeem Salami; Abayomi Fadeyi; Akingbade Adebayo Akin-Dosumu; Ibraheem M Rasheedat
Journal:  Niger Med J       Date:  2017 Mar-Apr

7.  An Emerging Syndemic of Smoking and Cardiopulmonary Diseases in People Living with HIV in Africa.

Authors:  Emmanuel Peprah; Mari Armstrong-Hough; Stephanie H Cook; Barbara Mukasa; Jacquelyn Y Taylor; Huichun Xu; Linda Chang; Joyce Gyamfi; Nessa Ryan; Temitope Ojo; Anya Snyder; Juliet Iwelunmor; Oliver Ezechi; Conrad Iyegbe; Paul O'Reilly; Andre Pascal Kengne
Journal:  Int J Environ Res Public Health       Date:  2021-03-18       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.